Functional autoantibodies could represent a significant piece in the puzzle of SSc pathogenesis and may open new gateways and opportunities for therapeutic intervention. PubMed, Curr Rheumatol Rep, 2015 May;17(5):505. (Also see Autoantibodies)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.